CCEL Relative Valuation
CCEL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CCEL is overvalued; if below, it's undervalued.
Historical Valuation
Cryo-Cell International Inc (CCEL) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 20.26. The fair price of Cryo-Cell International Inc (CCEL) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：4.03
Fair
-10.13
PE
1Y
3Y
5Y
Trailing
Forward
13.93
EV/EBITDA
Cryo-Cell International Inc. (CCEL) has a current EV/EBITDA of 13.93. The 5-year average EV/EBITDA is 13.17. The thresholds are as follows: Strongly Undervalued below -5.07, Undervalued between -5.07 and 4.05, Fairly Valued between 22.29 and 4.05, Overvalued between 22.29 and 31.41, and Strongly Overvalued above 31.41. The current Forward EV/EBITDA of 13.93 falls within the Historic Trend Line -Fairly Valued range.
55.25
EV/EBIT
Cryo-Cell International Inc. (CCEL) has a current EV/EBIT of 55.25. The 5-year average EV/EBIT is -416.00. The thresholds are as follows: Strongly Undervalued below -4174.02, Undervalued between -4174.02 and -2295.01, Fairly Valued between 1463.02 and -2295.01, Overvalued between 1463.02 and 3342.03, and Strongly Overvalued above 3342.03. The current Forward EV/EBIT of 55.25 falls within the Historic Trend Line -Fairly Valued range.
1.03
PS
Cryo-Cell International Inc. (CCEL) has a current PS of 1.03. The 5-year average PS is 1.32. The thresholds are as follows: Strongly Undervalued below -0.27, Undervalued between -0.27 and 0.53, Fairly Valued between 2.12 and 0.53, Overvalued between 2.12 and 2.92, and Strongly Overvalued above 2.92. The current Forward PS of 1.03 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
Cryo-Cell International Inc. (CCEL) has a current P/OCF of 0.00. The 5-year average P/OCF is 4.17. The thresholds are as follows: Strongly Undervalued below -14.37, Undervalued between -14.37 and -5.10, Fairly Valued between 13.44 and -5.10, Overvalued between 13.44 and 22.71, and Strongly Overvalued above 22.71. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
Cryo-Cell International Inc. (CCEL) has a current P/FCF of 0.00. The 5-year average P/FCF is -3.63. The thresholds are as follows: Strongly Undervalued below -33.36, Undervalued between -33.36 and -18.50, Fairly Valued between 11.23 and -18.50, Overvalued between 11.23 and 26.09, and Strongly Overvalued above 26.09. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
Cryo-Cell International Inc (CCEL) has a current Price-to-Book (P/B) ratio of -2.09. Compared to its 3-year average P/B ratio of -230.34 , the current P/B ratio is approximately -99.09% higher. Relative to its 5-year average P/B ratio of -140.84, the current P/B ratio is about -98.52% higher. Cryo-Cell International Inc (CCEL) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 2.99%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 4.47% , the current FCF yield is about -100.00% lower.
-2.15
P/B
Median3y
-230.34
Median5y
-140.84
19.94
FCF Yield
Median3y
2.99
Median5y
4.47
Competitors Valuation Multiple
The average P/S ratio for CCEL's competitors is 0.00, providing a benchmark for relative valuation. Cryo-Cell International Inc Corp (CCEL) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of -2.99%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of CCEL decreased by 46.69% over the past 1 year. The primary factor behind the change was an decrease in Revenue Growth from 8.07M to 7.83M.
The secondary factor is the P/E Change, contributed -17.17%to the performance.
Overall, the performance of CCEL in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch
FAQ
Is Cryo-Cell International Inc (CCEL) currently overvalued or undervalued?
What is Cryo-Cell International Inc (CCEL) fair value?
How does CCEL's valuation metrics compare to the industry average?
What is the current P/B ratio for Cryo-Cell International Inc (CCEL) as of Dec 05 2025?
What is the current FCF Yield for Cryo-Cell International Inc (CCEL) as of Dec 05 2025?
What is the current Forward P/E ratio for Cryo-Cell International Inc (CCEL) as of Dec 05 2025?